Overcoming Unique Client Challenges With A Strong Collaborative Partnership

A leading radiopharmaceutical company developing novel cancer therapies partnered with Labcorp to conduct small animal efficacy studies — a scarce capability in the industry. As the relationship deepened, the scope expanded to include assay development, model generation (from cell modification to full model creation), biodistribution, and tolerance and efficacy studies.

The client’s program faced unique challenges: test articles with strict handling requirements, limited stability, and narrow manufacturing timelines. With multiple compounds in development, seamless progression from biodistribution to efficacy work required careful planning and precise execution to avoid delays.

Through close collaboration, proactive communication, and agile project management, Labcorp accelerated the client’s oncology program and helped overcome complex preclinical hurdles with efficiency and precision.